Catalyst Funds Management’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-400	Closed	-$71.2K	–	1390
2024 Q1	$71.2K	Buy	+400	New	+$71.2K	0.02%	478